NovoCure Ltd Insider Trading for July 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for July 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.05 | 1,100 | 40,755 | 116,585 | 117.7 K to 116.6 K (-0.93 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 36.60 | 6,095 | 223,077 | 117,685 | 123.8 K to 117.7 K (-4.92 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.20 | 34,385 | 1,210,352 | 123,780 | 158.2 K to 123.8 K (-21.74 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 34.44 | 17,437 | 600,530 | 158,165 | 175.6 K to 158.2 K (-9.93 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 33.86 | 3,710 | 125,621 | 175,602 | 179.3 K to 175.6 K (-2.07 %) |
| Jul 18 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 0.00 | 27,685 | 0 | 1,071,054 | 1.1 M to 1.1 M (-2.52 %) |
| Jul 18 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 0.00 | 2,315 | 0 | 1,098,739 | 1.1 M to 1.1 M (-0.21 %) |
| Jul 18 2018 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 3.59 | 2,330 | 8,365 | 0 | |
| Jul 18 2018 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 3.59 | 2,330 | 8,365 | 914,473 | 912.1 K to 914.5 K (+0.26 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 17.26 | 1,231 | 21,241 | 5,231 | 4 K to 5.2 K (+30.78 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Grant | A | 17.26 | 1,231 | 21,241 | 21,305 | 20.1 K to 21.3 K (+6.13 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Grant | A | 17.26 | 1,231 | 21,241 | 109,063 | 107.8 K to 109.1 K (+1.14 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 17.26 | 1,191 | 20,551 | 179,312 | 178.1 K to 179.3 K (+0.67 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Grant | A | 17.26 | 795 | 13,718 | 70,113 | 69.3 K to 70.1 K (+1.15 %) |
| Jul 05 2018 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 7.48 | 29,565 | 221,146 | 0 | |
| Jul 05 2018 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 7.03 | 27,825 | 195,610 | 0 | |
| Jul 05 2018 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 31.48 | 57,390 | 1,806,637 | 146,558 | 203.9 K to 146.6 K (-28.14 %) |
| Jul 05 2018 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 7.48 | 29,565 | 221,146 | 203,948 | 174.4 K to 203.9 K (+16.95 %) |
| Jul 05 2018 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 7.03 | 27,825 | 195,610 | 174,383 | 146.6 K to 174.4 K (+18.99 %) |